Novitium Pharma LLC has recalled 1,003 bottles of Digoxin Tablets, USP (62.5 mcg or 0.0625 mg), a prescription medication used to treat heart failure and certain heart rhythm problems. The recall was issued because the tablets failed to meet required specifications for impurities and degradation during testing. If you are taking this medication, do not stop without consulting a medical professional, as Digoxin is a critical treatment for heart conditions.
The presence of impurities or degradation products in medication can result in the treatment being less effective or potentially causing unexpected side effects. While this is a low-risk recall, patients may not receive the intended therapeutic benefit of the drug.
You have 2 options:
Rx Only. Manufactured by Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.